Yeast-Based Drug Discovery:

The humanized yeast model has emerged as a powerful tool in large-scale screenings directed to target human proteins. The high degree of cellular processes conservation between the yeast Saccharomyces cerevisiae and higher eukaryotes has made this microorganism a valuable cell model to study the pathobiology of several human diseases. The yeast target-based approach can be highly useful in the first-line screening of potentially active compounds to be tested in more complex cell models.

 

 

  • Yeast as a model for human diseases and drug testing

Related Conference of Yeast-Based Drug Discovery:

February 20-21, 2019 |

8th Annual Summit on Microbiology

San Francisco, California, USA
March 18-19, 2019

3rd International Conference on Microbial Ecology & Eco Systems

Chicago, Illinois, USA
(10 Plenary Forums 2 days 1 event)
March 04-06, 2019

9th Global Summit on Microbiology & Infectious Diseases

Prague, Czech Republic
May 01-02, 2019

3rd International Conference on Medical and Clinical Microbiology

| ANA Crowne Plaza | Kyoto, Japan
May 20-21, 2019

4th International Conference on Applied Microbiology and Beneficial Microbes

| Radisson Hotel Narita | Tokyo , Japan
June 24-25, 2019

48th World Congress on Microbiology

Moscow, Russia
July 01-02, 2019

11th International Virology Summit

Valencia, spain
July 26-27, 2019

World Yeast Congress

Vancouver | Canada
October 23-24, 2019

2nd Global Experts Meeting on Chronic Diseases

| Radisson Hotel Narita | Tokyo, Japan
24-25 October, 2019

6th World Congress and Expo on Applied Microbiology

Rome, Italy
December 12-13, 2019

23rd World Congress on Biotechnology

Auckland, New Zealand

Yeast-Based Drug Discovery: Conference Speakers

Recommended Sessions

Related Journals

Are you interested in